Natural Products and Bio-Nanomaterials: Novel Strategies to Overcome Antibiotic Resistance
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Plant-Derived Antibiotics".
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 13338
Special Issue Editors
Interests: resistance; pharmacy; nanoparticles; bacterial control; in vivo model; resistance to antimicrobials
Special Issues, Collections and Topics in MDPI journals
Interests: nanotechnology
Special Issue Information
Dear Colleagues,
The emergence of superbugs is a concern in Public Health that accounts for millions of deaths in worldwide. Multidrug-resistant (MDR) microorganisms have increased in hospital environments and in communities, with high streaming rates. Conventional antimicrobials have not been effective enough in eliminating MDRs. So, new alternatives using natural products and nanoparticles can be interesting in infection control.
Natural products are a trend in biomedical applications as antimicrobials due to their low toxicity and environmental safety. Many different plants have been used as pharmaceuticals with benefits and advantages in infection control. However, this use alone presents some difficulties (cost, efficacy, seasonality, etc.) suggesting increments in their compounds.
Nanotechnology or Nanoscience is the study and application of small particles (between 1 and 100 nm) to produce new structures, material, and devices. This size and charge allow optimizing some physicochemical properties, as well as biological activities. Some nanomaterials with antimicrobial effects have been applied in the field of medicine with satisfactory results. These materials can adopt interesting strategies such as nanoencapsulation, compounds delivery, magnetic targeting and synergic associations.
In this way, our Special Issue will receive articles focusing on the antimicrobial activity using natural products (from marine, plants, microorganisms, etc.) and bionanomaterials for prevention or therapy against pathogens, including MDRs. Authors can send original research or review approaching this theme.
Dr. Renata Katsuko Takayama Kobayashi
Dr. Gerson Nakazato
Dr. Sara Scandorieiro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- material
- antimicrobial
- nature
- resistance
- nanoparticles
- strategy
